Login to Your Account



Califf sets out his top priorities for drug and device safety

By Mari Serebrov
Regulatory Editor

Thursday, March 3, 2016

In his first Senate budget hearing as FDA commissioner, Robert Califf committed Wednesday to more responsive interaction with lawmakers and a shoring up of the science behind the agency’s actions as he laid out his top priorities concerning drugs and devices.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription